Cargando…
Hemolytic uremic syndrome as the presenting manifestation of WT1 mutation and Denys-Drash syndrome: a case report
BACKGROUND: Hemolytic uremic syndrome (HUS) can occur as a primary process due to mutations in complement genes or secondary to another underlying disease. HUS sometimes occurs in the setting of glomerular diseases, and it has been described in association with Denys-Drash syndrome (DDS), which is c...
Autores principales: | Alge, Joseph L., Wenderfer, Scott E., Hicks, John, Bekheirnia, Mir Reza, Schady, Deborah A., Kain, Jamey S., Braun, Michael C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516385/ https://www.ncbi.nlm.nih.gov/pubmed/28720077 http://dx.doi.org/10.1186/s12882-017-0643-1 |
Ejemplares similares
-
Case Report: Denys–Drash Syndrome With WT1 Causative Variant Presenting as Atypical Hemolytic Uremic Syndrome
por: Cheng, Cheng, et al.
Publicado: (2020) -
A novel WT1 gene mutation in a chinese girl with denys‐drash syndrome
por: Wang, Faliang, et al.
Publicado: (2021) -
Clinical features and an atypical WT1 mutant site in a child with incomplete Denys–Drash syndrome
por: Wang, Hai-Yan, et al.
Publicado: (2014) -
Long-term outcome in a case series of Denys–Drash syndrome
por: Roca, Neus, et al.
Publicado: (2019) -
Bilateral Wilms’ tumors in an infant with Denys-Drash syndrome and rarely seen truncation mutation in the WT1 gene-exon 6
por: Modi, Jayesh, et al.
Publicado: (2015)